Platelet-Rich Plasma Therapy-Enhanced Ovarian Rejuvenation: Promising Approach Towards Ovarian Insufficiency and Fertility Preservation

Platelet-rich plasma (PRP) therapy shows promise as a non-invasive, cost-effective treatment for ovarian insufficiency and fertility preservation by enhancing ovarian repair, improving hormonal balance, and alleviating menopausal symptoms. The therapy increases blood flow, inhibits apoptosis, and promotes cellular repair, leading to improved outcomes in in vitro fertilization and potential benefits for conditions like polycystic ovarian syndrome and endometriosis. However, the optimal dosage, safety, and long-term effects remain uncertain, necessitating large-scale trials and follow-up studies to standardize its use in reproductive medicine.